[HTML][HTML] Efficacy of antibodies and antiviral drugs against Omicron BA. 2.12. 1, BA. 4, and BA. 5 subvariants
E Takashita, S Yamayoshi, V Simon… - … England Journal of …, 2022 - Mass Medical Soc
New England Journal of Medicine, 2022•Mass Medical Soc
Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5
Subvariants | NEJM Skip to main content NEJM Group Follow Us Facebook Twitter Instagram
YouTube LinkedIn Prepare to become a physician, build your knowledge, lead a health care
organization, and advance your career with NEJM Group information and services. NEJM
Evidence NEW! A digital journal for innovative original research and fresh, bold ideas in clinical
trial design and clinical decision-making. NEJM Catalyst NEW! Peer-reviewed journal featuring …
Subvariants | NEJM Skip to main content NEJM Group Follow Us Facebook Twitter Instagram
YouTube LinkedIn Prepare to become a physician, build your knowledge, lead a health care
organization, and advance your career with NEJM Group information and services. NEJM
Evidence NEW! A digital journal for innovative original research and fresh, bold ideas in clinical
trial design and clinical decision-making. NEJM Catalyst NEW! Peer-reviewed journal featuring …
In Vitro Activity of Antibodies and Drugs against Omicron
In this study, investigators who were evaluating in vitro neutralization of omicron subvariants by monoclonal antibodies and antiviral drugs found considerable variation among the agents.
The New England Journal Of Medicine